Skip links

Category: Analytics

Covid vaccine

Covid Vaccine- How close are we?

Covid Vaccine: Why did the need arise? In December 2019, reports flocked out of central city in Wuhan, China that a new coronavirus is causing a cluster of pneumonia cases in the city. On March 11, 2020, WHO declared the coronavirus as a pandemic and

Convalescent plasma: A promising old therapeutic approach

Convalescent plasma: A promising old therapeutic approach

Coronavirus disease 2019 (COVID-19), an acute respiratory disease whose outbreak has been declared a pandemic, infected more than 1.2 million people worldwide, killed 69,498 and 2,65,883 were recovered (as of Apr 6, 2020).1 Any approved vaccines or therapies for COVID-19? As of now, there are

Analytics – an integral part of the pharmaceutical spectrum

Analytics – an integral part of the pharmaceutical spectrum

“Applying big-data strategies to better inform decision making could generate up to $100 billion in value annually across the US health-care system, by optimizing innovation, improving the efficiency of research and clinical trials, and building new tools for physicians, consumers, insurers, and regulators to meet
Evolution of the global regulatory scenario

Evolution of the global regulatory scenario

Role of regulation and regulatory authorities: The entire healthcare ecosystem, from research to sales, is stringently regulated by governing authorities. These authorities include a number of local government regulatory agencies which ensure compliance in various legal and regulatory aspects of a drug. These agencies issue
Countries that will drive the global pharma market

Countries that will drive the global pharma market

The global pharma industry, in terms of worldwide prescription drug sales, is estimated to grow at ~6% CAGR and reach >$1 trillion in 2024. This is expected to be mainly driven by novel therapies, mainly biologics, in oncology, orphan drugs and gene therapy. Geographically, USA
“Cost-effective” innovations to drive the global pharma market

“Cost-effective” innovations to drive the global pharma market

The healthcare ecosystem is a complex network of multiple industries and organizations, all of which form an intertwined web of interdependencies. The industry, in terms of worldwide prescription drug sales, is estimated to grow at ~6% CAGR and reach >$1 trillion in 2024. There are some key
Contact Us